New PET scan for invasive lobular breast cancer
Treatments studied
Part of Cancer, Skin clinical trials.
This trial tests a special PET scan (F-FAPI PET) to image metastatic invasive lobular breast cancer. It aims to see if this scan gives a clearer picture than the standard PET scan, helping doctors track the cancer better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Willing to sign a consent form and follow the study schedule
- Able to comply with study procedures for the whole duration
- Female and older than 18 years
- Diagnosed with invasive lobular breast cancer that has spread (metastatic)
- Able to perform daily activities with mild or no help (ECOG 0-2)
- No planned change in cancer treatment between the two PET scans
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new type of PET/CT scan (using a tracer called FAPI-46) to find cancer spread in people with lobular breast cancer. It may be an option if your standard scan was unclear or negative.
This study tests a new imaging agent (18F-FAPI-04) for PET scans to see if it can better detect breast cancer or its spread. It may help doctors find tumors more clearly.
This study tests a new kind of PET/CT scan that uses a tracer called 18F-FAPI to see if it can better detect cancer in the lymph nodes under the arm after you've already had chemotherapy or targeted therapy before surgery. If successful, this could help doctors plan more precise surgery and avoid removing unnecessary lymph nodes.
This trial tests a new PET scan (called FFNP) to see if it can find which breast cancers stop responding to hormone therapy early. It's for people with advanced hormone-receptor-positive breast cancer who are starting a new endocrine treatment.
This study uses a special type of PET scan called FAPI PET to see if it can help detect or monitor cancer and other diseases. It is for people who already need a PET or CT/MRI scan as part of their standard care.
This trial compares two types of PET scans to see which one better detects ER-positive breast cancer. The results could help doctors choose the best scan for tracking your cancer.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.